Imatinib Treatment Alone in Philadelphia-Positive Acute Lymphoblastic Leukemia: Is It Enough

Publisher： Karger

E-ISSN： 1662-6575|4|2|323-326

ISSN： 1662-6575

Source： Case Reports in Oncology, Vol.4, Iss.2, 2011-06, pp. : 323-326

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Second-Generation Tyrosine Kinase Inhibitors in the Post-Transplant Period in Patients with Chronic Myeloid Leukemia or Philadelphia-Positive Acute Lymphoblastic Leukemia

By  

Acta Haematologica, Vol. 122, Iss. 1, 2009-07 ,pp. : 6-10

Karger

Access to resources Recommend Favorite

Long‐term follow‐up of imatinib plus combination chemotherapy in patients with newly diagnosed Philadelphia chromosome‐positive acute lymphoblastic leukemia

By  

AMERICAN JOURNAL OF HEMATOLOGY, Vol. 90, Iss. 11, 2015-11 ,pp. : 1013-1020

John Wiley & Sons Inc

Access to resources Recommend Favorite

Current paradigms in the management of Philadelphia chromosome positive acute lymphoblastic leukemia in adults

By  

AMERICAN JOURNAL OF HEMATOLOGY, Vol. 93, Iss. 2, 2018-02 ,pp. : 286-295

John Wiley & Sons Inc

Access to resources Recommend Favorite

Philadelphia-Positive Chronic-Phase Chronic Myeloid Leukaemia after Long-Term Remission of Philadelphia-Negative Acute Lymphoblastic Leukaemia

By  

Acta Haematologica, Vol. 119, Iss. 2, 2008-04 ,pp. : 124-125

Karger

Access to resources Recommend Favorite

Cannabis Extract Treatment for Terminal Acute Lymphoblastic Leukemia with a Philadelphia Chromosome Mutation

By  

Case Reports in Oncology, Vol. 6, Iss. 3, 2013-11 ,pp. : 585-592

Karger

Access to resources Recommend Favorite